• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Regulatory Affairs
  • UAMS Health
  • Jobs
  • Giving
  • Regulatory Affairs
    • ClinicalTrials.gov Registration
    • Good Tissue Practice
    • ORRA Monitoring Unit
      • Study Monitoring
      • Study Management Tools
        • Adverse Event Log (Device)
        • Adverse Event Log (Drug)
        • Compensation Log
        • Concomitant Medication Log
        • Delegation of Authority Log
        • Deviation Log
        • Device Accountability Log
        • Device Accountability Log (Use)
        • Eligibility Checklist
        • IND – IDE Monitoring Plan
        • Informed Consent Process Note
        • Regulatory Binder Contents
        • Role of the Medical Monitor
        • Screening-Enrollment Log
        • SIV Agenda
        • Source Data Agreement
        • Specimen Tracking Log
    • ORRA Regulatory Unit
      • Investigational Device Exemption Submission
      • Investigational New Drug Submission
  • Resources For Investigators
    • Research Resources
    • Useful Links
  • Research Policies
  • Contact
  • Staff Listing
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Office of Research Regulatory Affairs
  4. Regulatory Affairs
  5. Good Tissue Practice

Good Tissue Practice

The Good Tissue Practice specialist works with tissue establishments to ensure compliance with quality aspects as set forth by 21 CFR 1271 Subpart D – ‘Current Good Tissue Practice (cGTP)’.

The Good Tissue Practice specialist is responsible for the following:

  • Ensuring that tissue establishments establish and maintain appropriate procedures relating to core Good Tissue Practices requirements, and ensuring compliance with the requirements of Sec. 1271.180 with respect to such procedures, including review, approval, and revision;
  • Ensuring that procedures exist for receiving, investigating, evaluating, and documenting information relating to core Good Tissue Practices requirements, including complaints, and for sharing any information pertaining to the possible contamination of the human cells, tissues, and cellular and tissue-based products (HCT/P) or the potential for transmission of a communicable disease by the human cells, tissues, and cellular and tissue-based products;
  • Ensuring that appropriate corrective actions relating to core Good Tissue Practices requirements, including re-audits of deficiencies, are taken and documented, as necessary;
  • Ensuring the proper training and education of personnel involved in activities related to core Good Tissue Practices requirements;
  • Establishing and maintaining appropriate monitoring systems as necessary to comply with the requirements of this subpart (e.g., environmental monitoring);
  • Investigating and documenting human cells, tissues, and cellular and tissue-based products deviations and trends of human cells, tissues, and cellular and tissue-based products deviations relating to core Good Tissue Practices requirements and making reports if required under Sec. 1271.350(b) or other applicable regulations; and
  • Conducting annual quality audits as defined in Sec. 1271.3(gg), of activities related to core Good Tissue Practices requirements.

Staff Contact:

  • Beatrice Huey, BSW
    Good Tissue Practice Specialist
    BNHuey@uams.edu
    501-686-6286

Links

  • Tissue & Tissue Products
  • Current Good Tissue Practice (cGTP)
  • 21 CFR 1271
  • Tissue Guidances
University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences